|
WSB1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.777180E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.936100E-02 |
| Normal-vs-Stage2 |
4.492600E-01 |
| Normal-vs-Stage3 |
9.614200E-01 |
| Normal-vs-Stage4 |
2.981800E-01 |
| Stage1-vs-Stage2 |
2.773500E-02 |
| Stage1-vs-Stage3 |
4.160100E-02 |
| Stage1-vs-Stage4 |
8.164400E-01 |
| Stage2-vs-Stage3 |
4.677800E-01 |
| Stage2-vs-Stage4 |
1.355230E-01 |
| Stage3-vs-Stage4 |
2.810000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.714100E-02 |
| Normal-vs-AfricanAmerican |
9.634800E-01 |
| Normal-vs-Asian |
2.260000E-03 |
| Caucasian-vs-AfricanAmerican |
4.207200E-01 |
| Caucasian-vs-Asian |
2.220200E-02 |
| AfricanAmerican-vs-Asian |
2.556100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.416400E-01 |
| Normal-vs-Female |
2.071400E-01 |
| Male-vs-Female |
8.905200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.492200E-02 |
| Normal-vs-Age(41-60Yrs) |
1.972780E-01 |
| Normal-vs-Age(61-80Yrs) |
6.179400E-01 |
| Normal-vs-Age(81-100Yrs) |
3.975400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.133000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.698330E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.894400E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.701700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.102200E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.368000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.563950E-04 |
| Classical-VS-Follicular |
1.62039999995756E-06 |
| Classical-VS-Other |
3.634000E-01 |
| Classical-VS-Normal |
9.440300E-03 |
| Tall-VS-Follicular |
6.894400E-01 |
| Tall-VS-Other |
1.445780E-01 |
| Tall-VS-Normal |
2.705600E-01 |
| Follicular-VS-Other |
1.223850E-01 |
| Follicular-VS-Normal |
1.231220E-01 |
| Other-VS-Normal |
2.302400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.169800E-01 |
| Normal-vs-N1 |
1.864340E-03 |
| N0-vs-N1 |
1.820970E-03 |
|
|
